China Approves COVID-19 Vaccine For Human Trials In Military Personnel
- 4 years ago
Chinese officials have announced the approval of a COVID-19 vaccine for immediate use by military personnel.
According to UPI. the vaccine, Ad5-nCoV is currently being studied in clinical trials.
There is no word yet on how many of the 2.2 million Chinese military members will receive the vaccine.
Ad5-nCoV was developed by the Beijing Institute of Biotechnology, and biotechnology firm CanSino Biologics.
Globally there have been over 10 million confirmed cases of the novel coronavirus.
According to UPI. the vaccine, Ad5-nCoV is currently being studied in clinical trials.
There is no word yet on how many of the 2.2 million Chinese military members will receive the vaccine.
Ad5-nCoV was developed by the Beijing Institute of Biotechnology, and biotechnology firm CanSino Biologics.
Globally there have been over 10 million confirmed cases of the novel coronavirus.